The Ebiomedicine is reputed journal publishes research related to Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1). The ISSN of the journal is .
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | eBioMedicine |
|---|---|
| Publisher | Elsevier B.V. |
| Publication Country | Netherlands |
| ISSN | 23523964 |
| Publication Area | Biochemistry, Genetics and Molecular Biology; Medicine |
| Publication Language | ENG |
| Review Process | Double anonymous peer review |
| Scopus Indexed | Yes |
The Impact Factor of Ebiomedicine in 2026 is 11.2.
The Ebiomedicine is ranked in Q1.
The Ebiomedicine is indexed in: DOAJ, Web of Science.
There is a fee to publish in the Ebiomedicine. The publication fee is 6810 USD.
The journal also offers a fee waiver policy.
The Ebiomedicine takes an average of 27 weeks to publish research papers.
The official website of the journal is https://www.sciencedirect.com/journal/ebiomedicine.
Please visit only official website of the journal to submit research papers.